Hypotonic intraperitoneal cisplatin chemotherapy for peritoneal carcinomatosis in mice.
The intraperitoneal (i.p.) administration of cisplatin (CDDP) is one of the most effective therapies for cancers that are confined to the abdominal cavity. However, the effect of fluid osmolarity on the therapeutic efficacy of i.p. administration of CDDP has not been well established. In the current...
Main Authors: | , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
1996
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074519/ |